Crossmark Global Holdings, Inc. Glaukos Corp Transaction History
Crossmark Global Holdings, Inc.
- $5.22 Billion
- Q1 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 3,659 shares of GKOS stock, worth $436,482. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,659
Previous 3,634
0.69%
Holding current value
$436,482
Previous $289,000
19.38%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding GKOS
# of Institutions
273Shares Held
43.6MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$942 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$633 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$254 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$218 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$192 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.68B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...